
05/03/2025
We are thrilled to announce that Thermidas Oy has achieved a groundbreaking milestone. Our thermal imaging method has become the first of its kind in the world to receive Class IIa Medical Device CE certification.
Based on the latest clinical evaluation report, the product provides new insights into the analysis of diabetic foot ulcers, pressure injuries, vascular disorders, arthritis, skin cancer, and autonomic dysfunction in patients. These insights not only aid clinicians in making sound clinical decisions but may also empower patients with a greater awareness of their conditions, enabling them to actively participate in their own care.
This technology changes the paradigm in thermal imaging, providing unprecedented accuracy, speed, and cost-efficiency. With 17 years of dedicated development and comprehensive research, we have ensured the effectiveness and safety of our products, as required by the Medical Device Regulation (EU) 2017/745.
Thermidas is the first company globally to have CE marking for its thermal imaging product in Europe and FDA 510(k) clearance in the United States. This dual recognition positions us at the forefront of healthcare imaging technology, driving global advancements in medical practices.